407 related articles for article (PubMed ID: 31273954)
1. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
[TBL] [Abstract][Full Text] [Related]
2. Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa.
Costa RGF; Caro PL; de Matos-Neto EM; Lima JDCC; Radloff K; Alves MJ; Camargo RG; Pessoa AFM; Simoes E; Gama P; Cara DC; da Silva ASF; O Pereira W; Maximiano LF; de Alcântara PSM; Otoch JP; Trinchieri G; Laviano A; Muscaritoli M; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1116-1127. PubMed ID: 31307125
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway.
Alves MJ; Figuerêdo RG; Azevedo FF; Cavallaro DA; Neto NI; Lima JD; Matos-Neto E; Radloff K; Riccardi DM; Camargo RG; De Alcântara PS; Otoch JP; Junior ML; Seelaender M
BMC Cancer; 2017 Mar; 17(1):190. PubMed ID: 28288584
[TBL] [Abstract][Full Text] [Related]
4. Peritumoural adipose tissue pro-inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients.
Neto NIP; Murari ASP; Oyama LM; Otoch JP; Alcântara PSM; Tokeshi F; Figuerêdo RG; Alves MJ; Lima JDCC; Matos-Neto EM; Seelaender M; Oller do Nascimento CM
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1101-1108. PubMed ID: 30284380
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
[TBL] [Abstract][Full Text] [Related]
6. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.
Fukawa T; Yan-Jiang BC; Min-Wen JC; Jun-Hao ET; Huang D; Qian CN; Ong P; Li Z; Chen S; Mak SY; Lim WJ; Kanayama HO; Mohan RE; Wang RR; Lai JH; Chua C; Ong HS; Tan KK; Ho YS; Tan IB; Teh BT; Shyh-Chang N
Nat Med; 2016 Jun; 22(6):666-71. PubMed ID: 27135739
[TBL] [Abstract][Full Text] [Related]
7. The Role of Tumor Microenvironment Cells in Colorectal Cancer (CRC) Cachexia.
Kasprzak A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557173
[TBL] [Abstract][Full Text] [Related]
8. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib attenuates cachectic events in mice by modulating the expression of vascular endothelial growth factor.
Xu X; Jiang M; Zhang Y; Bi Y; Han M
Mol Med Rep; 2015 Jan; 11(1):289-94. PubMed ID: 25333891
[TBL] [Abstract][Full Text] [Related]
10. IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice.
Lai KC; Hong ZX; Hsieh JG; Lee HJ; Yang MH; Hsieh CH; Yang CH; Chen YR
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1314-1328. PubMed ID: 35170238
[TBL] [Abstract][Full Text] [Related]
11. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia.
Vaes RDW; van Dijk DPJ; Welbers TTJ; Blok MJ; Aberle MR; Heij L; Boj SF; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1509-1524. PubMed ID: 33047901
[TBL] [Abstract][Full Text] [Related]
12. Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia.
Dolly A; Pötgens SA; Thibaut MM; Neyrinck AM; de Castro GS; Galbert C; Lefevre C; Wyart E; Gomes SP; Gonçalves DC; Lanthier N; Baldin P; Huot JR; Bonetto A; Seelaender M; Delzenne NM; Sokol H; Bindels LB
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1569-1582. PubMed ID: 37127348
[TBL] [Abstract][Full Text] [Related]
13. Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients.
Talbert EE; Lewis HL; Farren MR; Ramsey ML; Chakedis JM; Rajasekera P; Haverick E; Sarna A; Bloomston M; Pawlik TM; Zimmers TA; Lesinski GB; Hart PA; Dillhoff ME; Schmidt CR; Guttridge DC
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):358-368. PubMed ID: 29316343
[TBL] [Abstract][Full Text] [Related]
14. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.
Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-induced cholestasis in cancer cachexia.
Thibaut MM; Sboarina M; Roumain M; Pötgens SA; Neyrinck AM; Destrée F; Gillard J; Leclercq IA; Dachy G; Demoulin JB; Tailleux A; Lestavel S; Rastelli M; Everard A; Cani PD; Porporato PE; Loumaye A; Thissen JP; Muccioli GG; Delzenne NM; Bindels LB
J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):70-90. PubMed ID: 33350058
[TBL] [Abstract][Full Text] [Related]
16. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients.
Fortunati N; Manti R; Birocco N; Pugliese M; Brignardello E; Ciuffreda L; Catalano MG; Aragno M; Boccuzzi G
Oncol Rep; 2007 Dec; 18(6):1521-7. PubMed ID: 17982639
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory signalling regulates eccentric contraction-induced protein synthesis in cachectic skeletal muscle.
Hardee JP; Counts BR; Gao S; VanderVeen BN; Fix DK; Koh HJ; Carson JA
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):369-383. PubMed ID: 29215198
[TBL] [Abstract][Full Text] [Related]
19. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients.
Batista ML; Olivan M; Alcantara PS; Sandoval R; Peres SB; Neves RX; Silverio R; Maximiano LF; Otoch JP; Seelaender M
Cytokine; 2013 Feb; 61(2):532-9. PubMed ID: 23200412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
